Article
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
Liver international : official journal of the International Association for the Study of the Liver - 1 Oct 2017
de Vries Elisabeth M G, Färkkilä Martti, Milkiewicz Piotr, Hov Johannes R, Eksteen Bertus, Thorburn Douglas, Chazouillères Olivier, Pares Albert, Nygård Ståle, Gilja Odd H, Wunsch Ewa, Invernizzi Pietro, Carbone Marco, Bernuzzi Francesca, Boberg Kirsten M, Røsjø Helge, Rosenberg William, Beuers Ulrich H, Ponsioen Cyriel Y, Karlsen Tom H, Vesterhus Mette
Abstract excerpt
BACKGROUND & AIMS: Biomarkers reflecting disease activity and prognosis in primary sclerosing cholangitis (PSC) have not been firmly established. Enhanced liver fibrosis (ELF) test was previously reported to predict outcome in PSC. We aimed to validate the prognostic utility of ELF test in an independent, multi-centre, retrospective PSC study population. METHODS: We collected serum samples from PSC patients from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.